Literature DB >> 3500530

Alteration of tryptophan metabolism in the synovial fluid of patients with rheumatoid arthritis and osteoarthritis.

T Igari1, M Tsuchizawa, T Shimamura.   

Abstract

Tryptophan, its metabolites and related enzyme activity in synovial fluid, blood and urine in patients with rheumatoid arthritis (RA) and osteoarthritis (OA) were measured. The levels of tryptophan, kynurenine and anthranilic acid in the synovial fluid higher in RA were than in OA, whereas the xanthurenic acid level was equal in RA and OA. Indoleamine 2, 3-dioxygenase activity in the synovial membrane was higher in RA than in OA. 5-Hydroxytryptamine (5-HT) levels in the synovial fluid and the blood and the 5-hydroxyindole acetic acid (5-HIAA) level in the synovial fluid were essentially the same for both diseases. However, the 5-HIAA level in the serum of RA patients was higher than in those with OA, and the 5-HIAA level in the urine of RA patients was lower than in those with OA. In addition, monoamine oxidase-A and B activity in the synovial fluid of RA patients was decreased than in those with OA. These findings suggest that metabolism of tryptophan is altered in patients with RA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500530     DOI: 10.1620/tjem.153.79

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  13 in total

1.  Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts.

Authors:  Mi-Kyung Park; Hye-Jwa Oh; Yang-Mi Heo; Eun-Mi Park; Mi-La Cho; Ho-Youn Kim; Sung-Hwan Park
Journal:  Exp Mol Med       Date:  2011-08-31       Impact factor: 8.718

2.  Investigation of the relationships between knee osteoarthritis and obesity via untargeted metabolomics analysis.

Authors:  Onur Senol; Gulsah Gundogdu; Koksal Gundogdu; Fatma Demirkaya Miloglu
Journal:  Clin Rheumatol       Date:  2019-01-14       Impact factor: 2.980

3.  Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients.

Authors:  Yesim Ozkan; Guray Mete; Aylin Sepici-Dincel; Vesile Sepici; Bolkan Simsek
Journal:  Clin Rheumatol       Date:  2011-05-10       Impact factor: 2.980

4.  Correlations between metabolites in the synovial fluid and serum: A mouse injury study.

Authors:  Cameron W Wallace; Brady Hislop; Alyssa K Hahn; Ayten E Erdogan; Priyanka P Brahmachary; Ronald K June
Journal:  J Orthop Res       Date:  2022-03-14       Impact factor: 3.102

5.  Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitus.

Authors:  Gregory Oxenkrug; Marieke van der Hart; Paul Summergrad
Journal:  Integr Mol Med       Date:  2015-09-25

6.  Anthranilic Acid: A Potential Biomarker and Treatment Target for Schizophrenia.

Authors:  Gregory Oxenkrug; Marieke van der Hart; Julien Roeser; Paul Summergrad
Journal:  Ann Psychiatry Ment Health       Date:  2016-01-30

7.  Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.

Authors:  Armin Birner; Martina Platzer; Susanne Astrid Bengesser; Nina Dalkner; Frederike T Fellendorf; Robert Queissner; Rene Pilz; Philipp Rauch; Alexander Maget; Carlo Hamm; Simone Herzog-Eberhard; Harald Mangge; Dietmar Fuchs; Natalie Moll; Sieglinde Zelzer; Gregor Schütze; Markus Schwarz; Bernd Reininghaus; Hans-Peter Kapfhammer; Eva Z Reininghaus
Journal:  PLoS One       Date:  2017-02-27       Impact factor: 3.240

8.  Supplement of 5-hydroxytryptophan before induction suppresses inflammation and collagen-induced arthritis.

Authors:  Tao-Hsiang Yang; Peng-Yang Hsu; Menghsiao Meng; Che-Chun Su
Journal:  Arthritis Res Ther       Date:  2015-12-15       Impact factor: 5.156

Review 9.  Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions.

Authors:  Elisa Wirthgen; Andreas Hoeflich; Alexander Rebl; Juliane Günther
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

Review 10.  IDO and Kynurenine Metabolites in Peripheral and CNS Disorders.

Authors:  Yi-Shu Huang; Joy Ogbechi; Felix I Clanchy; Richard O Williams; Trevor W Stone
Journal:  Front Immunol       Date:  2020-03-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.